Yuta Tanaka

Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report

Daisaku Sato, T. Iguchi, Yuri Kanno, 2021, Drug Safety.

Safety and effectiveness of pembrolizumab monotherapy in Japanese patients with unresectable urothelial carcinoma: a nation-wide post-marketing surveillance

N. Yamamoto, Yuichiro Ito, M. Ozaki, 2023, BMC Cancer.